We’ve also begun drug discovery efforts of our own,’ Anthropic says, as it buys Mithril and reports Claude results from six ...
Astra Zeneca and CSL have publicly endorsed Clever Culture's APAS agar plate reading tech – or at least they have come close ...
Explore the benefits, limitations, and gate-drive challenges of GaN power switches with detailed insights and Infineon's ...
Tech Times on MSN
Patient dies in BMS multiple sclerosis CAR T trial; company cannot link death to drug
CAR T therapy multiple sclerosis trial death: Bristol Myers Squibb disclosed the first fatality in its Phase 1 Breakfree-2 ...
BioNTech SE and Bristol Myers Squibb Company reported initial results from the global Phase 2 ROSETTA Lung-107 study of ...
Pathos AI launches multi-year collaborations to build an AI-driven dataset for Alzheimer’s and other neurological diseases.
(NASDAQ: TEM, “Tempus”) today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY, “BMS”), under which BMS ...
Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of ...
Tempus to build a de-identified dataset from hundreds of thousands of patients with neurological conditions; Pathos to ...
IHI, in partnership with Bristol Myers Squibb (BMS), is launching a new Cancer Collective Action Collaborative.
Solar energy is no longer just about a solar panel converting power to the grid. Households and businesses are now looking at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results